Market Intelligence Resource | December 3, 2020

Medicare FFS Part B & International Drug Prices: A Comparison Of The Top 50 Drugs

On November 20, 2020, the U.S. Department of Health and Human Services published this issue brief comparison of Medicare fee-for-service part B and international drug prices for the top 50 prescription drugs. This issue brief expands earlier drug pricing analysis: expands the list of drugs, expands the countries analyzed, and makes changes to the methodology compared to the previous analysis . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

About

Contact

Partnership

Medicare FFS Part B & International Drug Prices: A Comparison Of The Top 50 Drugs

Tagged As:

About

Contact

Partnership

Markets

Services

Customers

Publications

Markets

Topics

Executive Institutes

Professional Development Programs

Tools

Assessments

Tagged As: